imfinzi
astrazeneca ab - durvalumab - karcinom, pljučni pljuč - antineoplastična sredstva - non-small cell lung cancer (nsclc)imfinzi as monotherapy is indicated for the treatment of locally advanced, unresectable non small cell lung cancer (nsclc) in adults whose tumours express pd-l1 on ≥ 1% of tumour cells and whose disease has not progressed following platinum based chemoradiation therapy (see section 5. imfinzi in combination with tremelimumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic nsclc with no sensitising egfr mutations or alk positive mutations. small cell lung cancer (sclc)imfinzi in combination with etoposide and either carboplatin or cisplatin is indicated for the first-line treatment of adults with extensive-stage small cell lung cancer (es-sclc). biliary tract cancer (btc)imfinzi in combination with gemcitabine and cisplatin is indicated for the first line treatment of adults with unresectable or metastatic biliary tract cancer (btc). hepatocellular carcinoma (hcc)imfinzi in combination with tremelimumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc).
octagam 100 mg/ml raztopina za infundiranje
octapharma (ip) ltd., - polispecifični imunoglobulin, humani - raztopina za infundiranje - polispecifični imunoglobulin, humani 100 mg / 1 ml - humani imunoglobulini za intravaskularno aplikacijo
gammanorm 165 mg/ml raztopina za injiciranje
octapharma (ip) ltd., - polispecifični imunoglobulin, humani - raztopina za injiciranje - polispecifični imunoglobulin, humani 165 mg / 1 ml - humani imunoglobulini za ekstravaskularno aplikacijo
ledaga
helsinn birex pharmaceuticals ltd. - chlormethine - mycosis fungoides - antineoplastična sredstva - zdravilo ledaga je indicirano za lokalno zdravljenje kožnega limfoma t-celic tipa mungosis fungoidov (mf-tipa ctcl) pri odraslih bolnikih.
gammanorm 165 mg/ml raztopina za injiciranje
octapharma (ip) sprl - polispecifični imunoglobulin, humani - raztopina za injiciranje - polispecifični imunoglobulin, humani 165 mg / 1 ml - humani imunoglobulini za ekstravaskularno aplikacijo
gammanorm 165 mg/ml raztopina za injiciranje
octapharma (ip) sprl - polispecifični imunoglobulin, humani - raztopina za injiciranje - polispecifični imunoglobulin, humani 165 mg / 1 ml - humani imunoglobulini za ekstravaskularno aplikacijo
gammanorm 165 mg/ml raztopina za injiciranje
octapharma (ip) sprl - polispecifični imunoglobulin, humani - raztopina za injiciranje - polispecifični imunoglobulin, humani 165 mg / 1 ml - humani imunoglobulini za ekstravaskularno aplikacijo
gammanorm 165 mg/ml raztopina za injiciranje
octapharma (ip) sprl - polispecifični imunoglobulin, humani - raztopina za injiciranje - polispecifični imunoglobulin, humani 165 mg / 1 ml - humani imunoglobulini za ekstravaskularno aplikacijo
octagam 50 mg/ml raztopina za infundiranje
octapharma (ip) sprl - polispecifični imunoglobulin, humani - raztopina za infundiranje - polispecifični imunoglobulin, humani 50 mg / 1 ml - humani imunoglobulini za intravaskularno aplikacijo
octagam 50 mg/ml raztopina za infundiranje
octapharma (ip) sprl - polispecifični imunoglobulin, humani - raztopina za infundiranje - polispecifični imunoglobulin, humani 50 mg / 1 ml - humani imunoglobulini za intravaskularno aplikacijo